A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
暂无分享,去创建一个
K. Yoneyama | K. Nogami | K. Amano | M. Shima | S. Higasa | T. Okamura | Y. Ogawa | E. Sakaida | M. Saito | N. Hattori | Y. Seki | N. Suzuki | Toshihiro Ito | Ryoto Ozaki | R. Kobayashi